nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—Scleral discolouration—Varenicline—nicotine dependence	0.159	0.196	CcSEcCtD
Sildenafil—Dissociation—Varenicline—nicotine dependence	0.038	0.0467	CcSEcCtD
Sildenafil—Blindness transient—Varenicline—nicotine dependence	0.0302	0.0371	CcSEcCtD
Sildenafil—Myopia—Varenicline—nicotine dependence	0.0252	0.031	CcSEcCtD
Sildenafil—Vitreous floaters—Varenicline—nicotine dependence	0.0243	0.0298	CcSEcCtD
Sildenafil—Enterocolitis—Varenicline—nicotine dependence	0.0199	0.0244	CcSEcCtD
Sildenafil—Varicose vein—Varenicline—nicotine dependence	0.0148	0.0182	CcSEcCtD
Sildenafil—Sinus congestion—Varenicline—nicotine dependence	0.0111	0.0136	CcSEcCtD
Sildenafil—Transient ischaemic attack—Varenicline—nicotine dependence	0.0109	0.0134	CcSEcCtD
Sildenafil—Night sweats—Varenicline—nicotine dependence	0.0102	0.0126	CcSEcCtD
Sildenafil—Urine abnormality—Varenicline—nicotine dependence	0.00996	0.0122	CcSEcCtD
Sildenafil—Sexual dysfunction—Varenicline—nicotine dependence	0.00983	0.0121	CcSEcCtD
Sildenafil—Urine analysis abnormal—Varenicline—nicotine dependence	0.00937	0.0115	CcSEcCtD
Sildenafil—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00849	0.0513	CbGpPWpGaD
Sildenafil—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00841	0.0103	CcSEcCtD
Sildenafil—PDE6G—Diseases associated with visual transduction—AKR1B10—nicotine dependence	0.00826	0.0499	CbGpPWpGaD
Sildenafil—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00817	0.01	CcSEcCtD
Sildenafil—Laryngeal pain—Varenicline—nicotine dependence	0.00809	0.00994	CcSEcCtD
Sildenafil—Hyperlipidaemia—Varenicline—nicotine dependence	0.00765	0.0094	CcSEcCtD
Sildenafil—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.00727	0.0439	CbGpPWpGaD
Sildenafil—Scotoma—Varenicline—nicotine dependence	0.00726	0.00892	CcSEcCtD
Sildenafil—Gingivitis—Varenicline—nicotine dependence	0.00702	0.00863	CcSEcCtD
Sildenafil—Mydriasis—Varenicline—nicotine dependence	0.00691	0.0085	CcSEcCtD
Sildenafil—Rhinorrhoea—Varenicline—nicotine dependence	0.0068	0.00836	CcSEcCtD
Sildenafil—Endocrine disorder—Varenicline—nicotine dependence	0.00665	0.00817	CcSEcCtD
Sildenafil—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00655	0.0396	CbGpPWpGaD
Sildenafil—Eye irritation—Varenicline—nicotine dependence	0.00646	0.00794	CcSEcCtD
Sildenafil—Accidental injury—Varenicline—nicotine dependence	0.00623	0.00766	CcSEcCtD
Sildenafil—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.0061	0.0075	CcSEcCtD
Sildenafil—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00603	0.0364	CbGpPWpGaD
Sildenafil—Lacrimation increased—Varenicline—nicotine dependence	0.00598	0.00735	CcSEcCtD
Sildenafil—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00597	0.0361	CbGpPWpGaD
Sildenafil—Nocturia—Varenicline—nicotine dependence	0.00594	0.00731	CcSEcCtD
Sildenafil—Musculoskeletal pain—Varenicline—nicotine dependence	0.00558	0.00686	CcSEcCtD
Sildenafil—Abnormal dreams—Varenicline—nicotine dependence	0.00545	0.0067	CcSEcCtD
Sildenafil—Eructation—Varenicline—nicotine dependence	0.00542	0.00666	CcSEcCtD
Sildenafil—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.00526	0.0318	CbGpPWpGaD
Sildenafil—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00525	0.0317	CbGpPWpGaD
Sildenafil—Photophobia—Varenicline—nicotine dependence	0.00518	0.00636	CcSEcCtD
Sildenafil—Dry eye—Varenicline—nicotine dependence	0.00509	0.00626	CcSEcCtD
Sildenafil—Oesophagitis—Varenicline—nicotine dependence	0.00504	0.00619	CcSEcCtD
Sildenafil—Mouth ulceration—Varenicline—nicotine dependence	0.00498	0.00613	CcSEcCtD
Sildenafil—CYP1A1—Xenobiotics—CYP2A7—nicotine dependence	0.00496	0.03	CbGpPWpGaD
Sildenafil—Hypertonia—Varenicline—nicotine dependence	0.00483	0.00594	CcSEcCtD
Sildenafil—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.0047	0.0284	CbGpPWpGaD
Sildenafil—Diabetes mellitus—Varenicline—nicotine dependence	0.0046	0.00566	CcSEcCtD
Sildenafil—Deafness—Varenicline—nicotine dependence	0.00447	0.0055	CcSEcCtD
Sildenafil—Eye pain—Varenicline—nicotine dependence	0.00443	0.00545	CcSEcCtD
Sildenafil—Injury—Varenicline—nicotine dependence	0.00435	0.00535	CcSEcCtD
Sildenafil—Hot flush—Varenicline—nicotine dependence	0.00428	0.00526	CcSEcCtD
Sildenafil—Increased appetite—Varenicline—nicotine dependence	0.00426	0.00524	CcSEcCtD
Sildenafil—Menopausal symptoms—Varenicline—nicotine dependence	0.00424	0.00521	CcSEcCtD
Sildenafil—Atrial fibrillation—Varenicline—nicotine dependence	0.00422	0.00519	CcSEcCtD
Sildenafil—Visual disturbance—Varenicline—nicotine dependence	0.00422	0.00519	CcSEcCtD
Sildenafil—Thirst—Varenicline—nicotine dependence	0.0042	0.00517	CcSEcCtD
Sildenafil—Arthritis—Varenicline—nicotine dependence	0.00412	0.00506	CcSEcCtD
Sildenafil—Hypoglycaemia—Varenicline—nicotine dependence	0.0041	0.00504	CcSEcCtD
Sildenafil—Cerebrovascular accident—Varenicline—nicotine dependence	0.00408	0.00502	CcSEcCtD
Sildenafil—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00406	0.0245	CbGpPWpGaD
Sildenafil—Osteoarthritis—Varenicline—nicotine dependence	0.004	0.00492	CcSEcCtD
Sildenafil—Migraine—Varenicline—nicotine dependence	0.00394	0.00484	CcSEcCtD
Sildenafil—Irritability—Varenicline—nicotine dependence	0.00382	0.0047	CcSEcCtD
Sildenafil—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00374	0.0226	CbGpPWpGaD
Sildenafil—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.0037	0.0224	CbGpPWpGaD
Sildenafil—Liver function test abnormal—Varenicline—nicotine dependence	0.00369	0.00454	CcSEcCtD
Sildenafil—Abdominal pain upper—Varenicline—nicotine dependence	0.00365	0.00449	CcSEcCtD
Sildenafil—Hypokalaemia—Varenicline—nicotine dependence	0.00364	0.00448	CcSEcCtD
Sildenafil—Breast disorder—Varenicline—nicotine dependence	0.00362	0.00445	CcSEcCtD
Sildenafil—Nasopharyngitis—Varenicline—nicotine dependence	0.00358	0.0044	CcSEcCtD
Sildenafil—Gastritis—Varenicline—nicotine dependence	0.00354	0.00435	CcSEcCtD
Sildenafil—Abdominal distension—Varenicline—nicotine dependence	0.00348	0.00428	CcSEcCtD
Sildenafil—Dysphagia—Varenicline—nicotine dependence	0.00346	0.00425	CcSEcCtD
Sildenafil—Asthma—Varenicline—nicotine dependence	0.00346	0.00425	CcSEcCtD
Sildenafil—Angina pectoris—Varenicline—nicotine dependence	0.00337	0.00414	CcSEcCtD
Sildenafil—Bronchitis—Varenicline—nicotine dependence	0.00333	0.00409	CcSEcCtD
Sildenafil—PDE6H—brain—nicotine dependence	0.0033	0.157	CbGeAlD
Sildenafil—Pollakiuria—Varenicline—nicotine dependence	0.00319	0.00393	CcSEcCtD
Sildenafil—Erectile dysfunction—Varenicline—nicotine dependence	0.00319	0.00392	CcSEcCtD
Sildenafil—Photosensitivity reaction—Varenicline—nicotine dependence	0.00316	0.00388	CcSEcCtD
Sildenafil—Weight increased—Varenicline—nicotine dependence	0.00315	0.00387	CcSEcCtD
Sildenafil—Hyperglycaemia—Varenicline—nicotine dependence	0.00312	0.00384	CcSEcCtD
Sildenafil—Infestation—Varenicline—nicotine dependence	0.00308	0.00379	CcSEcCtD
Sildenafil—Infestation NOS—Varenicline—nicotine dependence	0.00308	0.00379	CcSEcCtD
Sildenafil—Depression—Varenicline—nicotine dependence	0.00307	0.00378	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00306	0.00376	CcSEcCtD
Sildenafil—Acute coronary syndrome—Varenicline—nicotine dependence	0.00304	0.00374	CcSEcCtD
Sildenafil—Myocardial infarction—Varenicline—nicotine dependence	0.00302	0.00372	CcSEcCtD
Sildenafil—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00302	0.0182	CbGpPWpGaD
Sildenafil—Stomatitis—Varenicline—nicotine dependence	0.00301	0.0037	CcSEcCtD
Sildenafil—Conjunctivitis—Varenicline—nicotine dependence	0.003	0.00368	CcSEcCtD
Sildenafil—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00298	0.018	CbGpPWpGaD
Sildenafil—Epistaxis—Varenicline—nicotine dependence	0.00291	0.00358	CcSEcCtD
Sildenafil—Sinusitis—Varenicline—nicotine dependence	0.00289	0.00356	CcSEcCtD
Sildenafil—ADORA2A—cardiovascular system—nicotine dependence	0.00281	0.134	CbGeAlD
Sildenafil—Hypoaesthesia—Varenicline—nicotine dependence	0.00275	0.00339	CcSEcCtD
Sildenafil—Urinary tract disorder—Varenicline—nicotine dependence	0.00273	0.00336	CcSEcCtD
Sildenafil—Oedema peripheral—Varenicline—nicotine dependence	0.00273	0.00335	CcSEcCtD
Sildenafil—Connective tissue disorder—Varenicline—nicotine dependence	0.00272	0.00334	CcSEcCtD
Sildenafil—Urethral disorder—Varenicline—nicotine dependence	0.00271	0.00334	CcSEcCtD
Sildenafil—Visual impairment—Varenicline—nicotine dependence	0.00267	0.00328	CcSEcCtD
Sildenafil—Erythema multiforme—Varenicline—nicotine dependence	0.00262	0.00322	CcSEcCtD
Sildenafil—Eye disorder—Varenicline—nicotine dependence	0.00259	0.00318	CcSEcCtD
Sildenafil—Tinnitus—Varenicline—nicotine dependence	0.00258	0.00317	CcSEcCtD
Sildenafil—Cardiac disorder—Varenicline—nicotine dependence	0.00257	0.00316	CcSEcCtD
Sildenafil—PDE5A—cardiovascular system—nicotine dependence	0.00256	0.122	CbGeAlD
Sildenafil—Angiopathy—Varenicline—nicotine dependence	0.00251	0.00309	CcSEcCtD
Sildenafil—Immune system disorder—Varenicline—nicotine dependence	0.0025	0.00307	CcSEcCtD
Sildenafil—Mediastinal disorder—Varenicline—nicotine dependence	0.00249	0.00307	CcSEcCtD
Sildenafil—Chills—Varenicline—nicotine dependence	0.00248	0.00305	CcSEcCtD
Sildenafil—Arrhythmia—Varenicline—nicotine dependence	0.00247	0.00304	CcSEcCtD
Sildenafil—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00245	0.0148	CbGpPWpGaD
Sildenafil—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00244	0.0148	CbGpPWpGaD
Sildenafil—Mental disorder—Varenicline—nicotine dependence	0.00243	0.00298	CcSEcCtD
Sildenafil—Malnutrition—Varenicline—nicotine dependence	0.00241	0.00296	CcSEcCtD
Sildenafil—Erythema—Varenicline—nicotine dependence	0.00241	0.00296	CcSEcCtD
Sildenafil—Flatulence—Varenicline—nicotine dependence	0.00237	0.00292	CcSEcCtD
Sildenafil—Back pain—Varenicline—nicotine dependence	0.00233	0.00287	CcSEcCtD
Sildenafil—Vision blurred—Varenicline—nicotine dependence	0.00227	0.00279	CcSEcCtD
Sildenafil—Tremor—Varenicline—nicotine dependence	0.00226	0.00278	CcSEcCtD
Sildenafil—Ill-defined disorder—Varenicline—nicotine dependence	0.00224	0.00275	CcSEcCtD
Sildenafil—Anaemia—Varenicline—nicotine dependence	0.00223	0.00274	CcSEcCtD
Sildenafil—Agitation—Varenicline—nicotine dependence	0.00221	0.00272	CcSEcCtD
Sildenafil—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00219	0.0132	CbGpPWpGaD
Sildenafil—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00218	0.0132	CbGpPWpGaD
Sildenafil—Malaise—Varenicline—nicotine dependence	0.00217	0.00267	CcSEcCtD
Sildenafil—Vertigo—Varenicline—nicotine dependence	0.00217	0.00266	CcSEcCtD
Sildenafil—Syncope—Varenicline—nicotine dependence	0.00216	0.00266	CcSEcCtD
Sildenafil—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00216	0.013	CbGpPWpGaD
Sildenafil—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00215	0.013	CbGpPWpGaD
Sildenafil—Palpitations—Varenicline—nicotine dependence	0.00213	0.00262	CcSEcCtD
Sildenafil—Loss of consciousness—Varenicline—nicotine dependence	0.00212	0.0026	CcSEcCtD
Sildenafil—Cough—Varenicline—nicotine dependence	0.0021	0.00259	CcSEcCtD
Sildenafil—Convulsion—Varenicline—nicotine dependence	0.00209	0.00257	CcSEcCtD
Sildenafil—Hypertension—Varenicline—nicotine dependence	0.00208	0.00256	CcSEcCtD
Sildenafil—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00206	0.0124	CbGpPWpGaD
Sildenafil—Chest pain—Varenicline—nicotine dependence	0.00205	0.00252	CcSEcCtD
Sildenafil—Myalgia—Varenicline—nicotine dependence	0.00205	0.00252	CcSEcCtD
Sildenafil—Arthralgia—Varenicline—nicotine dependence	0.00205	0.00252	CcSEcCtD
Sildenafil—Anxiety—Varenicline—nicotine dependence	0.00204	0.00251	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00204	0.0025	CcSEcCtD
Sildenafil—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00203	0.0123	CbGpPWpGaD
Sildenafil—Discomfort—Varenicline—nicotine dependence	0.00203	0.00249	CcSEcCtD
Sildenafil—Dry mouth—Varenicline—nicotine dependence	0.00201	0.00247	CcSEcCtD
Sildenafil—Oedema—Varenicline—nicotine dependence	0.00197	0.00242	CcSEcCtD
Sildenafil—Infection—Varenicline—nicotine dependence	0.00195	0.0024	CcSEcCtD
Sildenafil—Shock—Varenicline—nicotine dependence	0.00193	0.00238	CcSEcCtD
Sildenafil—Nervous system disorder—Varenicline—nicotine dependence	0.00193	0.00237	CcSEcCtD
Sildenafil—Tachycardia—Varenicline—nicotine dependence	0.00192	0.00236	CcSEcCtD
Sildenafil—Skin disorder—Varenicline—nicotine dependence	0.00191	0.00235	CcSEcCtD
Sildenafil—Hyperhidrosis—Varenicline—nicotine dependence	0.0019	0.00234	CcSEcCtD
Sildenafil—Anorexia—Varenicline—nicotine dependence	0.00187	0.0023	CcSEcCtD
Sildenafil—Hypotension—Varenicline—nicotine dependence	0.00184	0.00226	CcSEcCtD
Sildenafil—ABCC5—midbrain—nicotine dependence	0.00183	0.087	CbGeAlD
Sildenafil—ABCC10—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00179	0.0108	CbGpPWpGaD
Sildenafil—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00179	0.0022	CcSEcCtD
Sildenafil—Insomnia—Varenicline—nicotine dependence	0.00178	0.00219	CcSEcCtD
Sildenafil—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00177	0.0107	CbGpPWpGaD
Sildenafil—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00177	0.0107	CbGpPWpGaD
Sildenafil—Dyspnoea—Varenicline—nicotine dependence	0.00175	0.00216	CcSEcCtD
Sildenafil—Somnolence—Varenicline—nicotine dependence	0.00175	0.00215	CcSEcCtD
Sildenafil—Dyspepsia—Varenicline—nicotine dependence	0.00173	0.00213	CcSEcCtD
Sildenafil—Decreased appetite—Varenicline—nicotine dependence	0.00171	0.0021	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Varenicline—nicotine dependence	0.0017	0.00209	CcSEcCtD
Sildenafil—Fatigue—Varenicline—nicotine dependence	0.0017	0.00208	CcSEcCtD
Sildenafil—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00169	0.0102	CbGpPWpGaD
Sildenafil—Constipation—Varenicline—nicotine dependence	0.00168	0.00207	CcSEcCtD
Sildenafil—Pain—Varenicline—nicotine dependence	0.00168	0.00207	CcSEcCtD
Sildenafil—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00167	0.0101	CbGpPWpGaD
Sildenafil—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00166	0.0101	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—FGD1—nicotine dependence	0.00165	0.00999	CbGpPWpGaD
Sildenafil—Feeling abnormal—Varenicline—nicotine dependence	0.00162	0.00199	CcSEcCtD
Sildenafil—Gastrointestinal pain—Varenicline—nicotine dependence	0.00161	0.00198	CcSEcCtD
Sildenafil—Urticaria—Varenicline—nicotine dependence	0.00156	0.00192	CcSEcCtD
Sildenafil—Abdominal pain—Varenicline—nicotine dependence	0.00155	0.00191	CcSEcCtD
Sildenafil—Body temperature increased—Varenicline—nicotine dependence	0.00155	0.00191	CcSEcCtD
Sildenafil—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00155	0.00937	CbGpPWpGaD
Sildenafil—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00154	0.00929	CbGpPWpGaD
Sildenafil—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00153	0.00925	CbGpPWpGaD
Sildenafil—ABCC10—midbrain—nicotine dependence	0.00153	0.0727	CbGeAlD
Sildenafil—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00152	0.00917	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00149	0.00902	CbGpPWpGaD
Sildenafil—Hypersensitivity—Varenicline—nicotine dependence	0.00145	0.00178	CcSEcCtD
Sildenafil—Asthenia—Varenicline—nicotine dependence	0.00141	0.00173	CcSEcCtD
Sildenafil—Pruritus—Varenicline—nicotine dependence	0.00139	0.00171	CcSEcCtD
Sildenafil—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00138	0.00833	CbGpPWpGaD
Sildenafil—ADORA2A—brain—nicotine dependence	0.00138	0.0656	CbGeAlD
Sildenafil—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00137	0.00826	CbGpPWpGaD
Sildenafil—Diarrhoea—Varenicline—nicotine dependence	0.00135	0.00165	CcSEcCtD
Sildenafil—Dizziness—Varenicline—nicotine dependence	0.0013	0.0016	CcSEcCtD
Sildenafil—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.0013	0.00785	CbGpPWpGaD
Sildenafil—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00128	0.00774	CbGpPWpGaD
Sildenafil—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00126	0.0076	CbGpPWpGaD
Sildenafil—PDE5A—brain—nicotine dependence	0.00125	0.0598	CbGeAlD
Sildenafil—Vomiting—Varenicline—nicotine dependence	0.00125	0.00154	CcSEcCtD
Sildenafil—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00125	0.00753	CbGpPWpGaD
Sildenafil—Rash—Varenicline—nicotine dependence	0.00124	0.00152	CcSEcCtD
Sildenafil—Dermatitis—Varenicline—nicotine dependence	0.00124	0.00152	CcSEcCtD
Sildenafil—Headache—Varenicline—nicotine dependence	0.00123	0.00151	CcSEcCtD
Sildenafil—Nausea—Varenicline—nicotine dependence	0.00117	0.00144	CcSEcCtD
Sildenafil—ADORA2A—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00115	0.00696	CbGpPWpGaD
Sildenafil—ABCC5—brain—nicotine dependence	0.00115	0.0547	CbGeAlD
Sildenafil—PDE6G—Signaling Pathways—TAS2R16—nicotine dependence	0.00106	0.0064	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKR1B10—nicotine dependence	0.00105	0.00634	CbGpPWpGaD
Sildenafil—CYP2C9—cardiovascular system—nicotine dependence	0.00105	0.0498	CbGeAlD
Sildenafil—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00101	0.00613	CbGpPWpGaD
Sildenafil—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.001	0.00605	CbGpPWpGaD
Sildenafil—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000999	0.00603	CbGpPWpGaD
Sildenafil—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000997	0.00602	CbGpPWpGaD
Sildenafil—CYP2E1—cardiovascular system—nicotine dependence	0.00099	0.0472	CbGeAlD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000964	0.00583	CbGpPWpGaD
Sildenafil—ABCC10—brain—nicotine dependence	0.000959	0.0457	CbGeAlD
Sildenafil—ABCC5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000942	0.00569	CbGpPWpGaD
Sildenafil—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000942	0.00569	CbGpPWpGaD
Sildenafil—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.000941	0.00569	CbGpPWpGaD
Sildenafil—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.000939	0.00567	CbGpPWpGaD
Sildenafil—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000928	0.00561	CbGpPWpGaD
Sildenafil—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000927	0.0056	CbGpPWpGaD
Sildenafil—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.000888	0.00536	CbGpPWpGaD
Sildenafil—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000875	0.00529	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—DRD2—nicotine dependence	0.000851	0.00514	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000843	0.00509	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—FGD1—nicotine dependence	0.000832	0.00502	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000826	0.00499	CbGpPWpGaD
Sildenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000822	0.00497	CbGpPWpGaD
Sildenafil—ABCC4—brain—nicotine dependence	0.000795	0.0379	CbGeAlD
Sildenafil—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00077	0.00465	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000766	0.00463	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKR1B10—nicotine dependence	0.000735	0.00444	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000726	0.00439	CbGpPWpGaD
Sildenafil—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000716	0.00433	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000709	0.00428	CbGpPWpGaD
Sildenafil—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000703	0.00424	CbGpPWpGaD
Sildenafil—ADORA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000697	0.00421	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000668	0.00403	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000662	0.004	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000662	0.004	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000659	0.00398	CbGpPWpGaD
Sildenafil—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000653	0.00395	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000653	0.00394	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000629	0.0038	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000601	0.00363	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000597	0.00361	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKR1B10—nicotine dependence	0.000567	0.00342	CbGpPWpGaD
Sildenafil—CYP1A1—brain—nicotine dependence	0.000533	0.0254	CbGeAlD
Sildenafil—PDE6G—Signaling Pathways—WASF2—nicotine dependence	0.000518	0.00313	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—WASF1—nicotine dependence	0.000496	0.003	CbGpPWpGaD
Sildenafil—CYP2E1—brain—nicotine dependence	0.000486	0.0232	CbGeAlD
Sildenafil—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000463	0.0028	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000455	0.00275	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000452	0.00273	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—OPRM1—nicotine dependence	0.000447	0.0027	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CYP2A7—nicotine dependence	0.000441	0.00266	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000437	0.00264	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000431	0.0026	CbGpPWpGaD
Sildenafil—CYP2D6—brain—nicotine dependence	0.000385	0.0183	CbGeAlD
Sildenafil—ADORA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000356	0.00215	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—FGD1—nicotine dependence	0.000355	0.00214	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—DRD2—nicotine dependence	0.000323	0.00195	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000323	0.00195	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000314	0.00189	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000257	0.00155	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000233	0.00141	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000222	0.00134	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—WASF2—nicotine dependence	0.000221	0.00133	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—WASF1—nicotine dependence	0.000212	0.00128	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000191	0.00115	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000161	0.000972	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000161	0.00097	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000152	0.000917	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—DRD2—nicotine dependence	0.000138	0.000833	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000124	0.00075	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000114	0.00069	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000113	0.000684	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP2A7—nicotine dependence	7.47e-05	0.000451	CbGpPWpGaD
